What is a key financing consideration for sponsors of clinical trials?

• A. Funding is not a concern for trial sponsors.
• B. Adequate funding to support all aspects of the trial.
• C. Funding is provided exclusively by regulatory authorities.
• D. Funding requires only initial capital.

Answer: (B)

Adequate funding to support all aspects of the trial is essential. Sponsors must have enough resources to cover every part of the study—from site start-up, patient recruitment and retention, and ongoing monitoring, to data management, safety reporting, statistical analysis, regulatory compliance, and final study closeout. If funds are insufficient, activities can be compromised, affecting participant safety, data integrity, and timelines. Regulatory authorities don’t typically provide trial funding, and funding isn’t limited to an initial capital outlay—the budget should span the entire trial duration and include contingencies.